Marina Bluma

Marina Bluma is a clinical neuroscientist specializing in neuroimaging, aging, and Alzheimer’s disease (AD). At the Nordberg Translational Molecular Imaging Lab, her research centers on amyloid PET, plasma biomarkers, and Alzheimer’s disease variability. In particular,   she is interested in how the timing of amyloid onset and the balance between soluble and insoluble amyloid shape differences in downstream biological pathways.

CV:
Sapienza University of Rome Rome, Italy
PHD IN CLINICAL/EXPERIMENTAL NEUROSCIENCE AND PSYCHIATRY (Jul. 2017 ‑ May 2021)
* Marie Skłodowska‑Curie Fellowship.
* Thesis: Translational EEG and structural MRI biomarkers of Alzheimer’s disease in patients and mouse models.
Goethe University Frankfurt, Germany

M.SC. IN INTERDISCIPLINARY NEUROSCIENCE (Oct. 2012 ‑ Jul.2015)
* Thesis: The neural correlates of monetary gambling in ASD ‑ an fMRI study
Saint Petersburg State University, Russia

DIPL. IN CLINICAL PSYCHOLOGY (Sep. 2006 ‑ Jun.2011)
* Thesis: Abnormal visual strategies for perception of social static scenes in patients with schizophrenia.

Plasma Biomarkers, Multimodal neuroimaging, Alzheimer’s disease.

@ JL University Giessen (Germany) in Aug. 2014 ‑ Exp. Apr. 2016.
course “Neuroimaging in Autism Spectrum Disorder”.